Table 3. Risk for Metabolic Abnormalities by Weight-for-Height Percentile.
| Dependent variables (metabolic abnormality) | Odds ratio (95% CI) by Weight-for-Height percentile group | |||
|---|---|---|---|---|
| <50 percentile | 50–74 percentile | 75–94 percentile | ≥95 percentile | |
| Unadjusted | ||||
| SBP/DBP ≥120/80 mmHg | 1.00 | 2.04 (1.18–3.54) | 4.35 (2.58–7.36) | 7.70 (3.85–15.40) |
| Total cholesterol ≥200 mg/dl | 1.00 | 1.31 (0.62–2.78) | 1.18 (0.51–2.72) | 2.89 (1.08–7.77) |
| Triglycerides ≥150 mg/dl | 1.00 | 1.94 (0.58–6.42) | 3.43 (1.11–10.64) | 7.79 (2.17–27.92) |
| AST or ALT ≥30 IU/l | 1.00 | 0.91 (0.37–2.20) | 1.84 (0.83–4.06) | 7.67 (3.31–17.75) |
| Fasting glucose ≥100 mg/dl | 1.00 | 1.11 (0.47–2.63) | 1.63 (0.70–3.80) | 1.68 (0.46–6.12) |
| HOMA-IR >2.50 | 1.00 | 1.36 (0.80–2.30) | 3.76 (2.32–6.10) | 10.88 (5.66–20.92) |
| HOMA-IR >3.16 | 1.00 | 2.14 (0.48–9.66) | 14.62 (4.26–50.11) | 50.00 (13.82–180.9) |
| Adjusted for sex and age | ||||
| SBP/DBP ≥120/80 mmHg | 1.00 | 2.40 (1.36–4.24) | 5.11 (2.95–8.85) | 10.08 (4.75–21.39) |
| Total cholesterol ≥200 mg/dl | 1.00 | 1.20 (0.56–2.56) | 1.13 (0.49–2.63) | 2.83 (1.04–7.71) |
| Triglycerides ≥150 mg/dl | 1.00 | 2.06 (0.62–6.86) | 3.56 (1.14–11.08) | 8.07 (2.23–29.22) |
| AST or ALT ≥30 IU/l | 1.00 | 1.02 (0.42–2.49) | 1.96 (0.88–4.39) | 9.37 (3.86–22.75) |
| Fasting glucose ≥100 mg/dl | 1.00 | 1.21 (0.50–2.89) | 1.69 (0.72–3.95) | 1.74 (0.47–6.39) |
| HOMA-IR >2.50 | 1.00 | 1.39 (0.81–2.36) | 3.87 (2.38–6.30) | 11.37 (5.87–22.02) |
| HOMA-IR >3.16 | 1.00 | 2.20 (0.49–9.94) | 14.80 (4.31–50.76) | 51.01 (14.07–185.0) |
Abbreviations: SBP, systolic blood pressure; DBP, diastolic blood pressure; AST, aspartate aminotransferase; ALT, alanine aminotransferase; HOMA-IR, Homeostasis model assessment insulin resistance.